Blocking a cellular switch could prevent lung-scarring disease
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Blocking a cellular switch could prevent lung-scarring disease
ESMO 2025: Men with BRCA1 and BRCA2 gene mutations should get annual prostate cancer screening - ICR
ESMO 2025: Thymic health linked to immunotherapy response
Study links obesity-driven fatty acids to breast cancer, warns against high-fat diets like keto
From molecular pathways to potential treatments: Targeting epithelial‒mesenchymal transition in glioblastoma
New combination therapy shows promise for aggressive lymphoma resistant to immunotherapy
New imaging solution could help improve survival for patients with recurring prostate cancer
Glue prevents complications after breast cancer surgery
Biomarker analysis reveals clues to long-term survival in glioblastoma patients treated with SurVaxM
Novel biomarker for prognosis and immunotherapy response in head and neck cancer
Molecular markers and risk models guide precision care in liver cancer surgery
New radiofrequency therapy slows glioblastoma growth and targets tumour stem cells